A observational trial to evaluate the efficacy of raltegravir once a daily in switching strategy in HIV-1 infected patients with suppressed viraemia
Latest Information Update: 06 Dec 2015
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 06 Dec 2015 New trial record